Laurent v. Takeda Pharmaceuticals America Inc. et al
Sidney J. Laurent, Jr. |
TAKEDA PHARMACEUTICALS USA, INC, TAKEDA PHARMACEUTICALS AMERICA, INC. and Takeda Pharmaceuticals U.S.A. Inc. |
1:2019cv08129 |
December 12, 2019 |
US District Court for the Northern District of Illinois |
John Robert Blakey |
Young B Kim |
Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
28 U.S.C. § 1332 |
Both |
Docket Report
This docket was last retrieved on February 5, 2020. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 23 CASE MANAGEMENT ORDER NO. 1 (establishing master case file, consolidating cases for pretrial purposes,and establishing coordinated discovery and pretrial schedule): Signed by the Honorable Matthew F. Kennelly on 2/5/2020. Mailed notice. (mma, ) |
Filing 22 EXECUTIVE COMMITTEE ORDER: Case referred to the Honorable Young B. Kim pursuant to IOP 13(e). It further appearing that the Hon. Matthew F. Kennelly, has agreed to preside over these proceedings; and It further appearing that Magistrate Judge Young B. Kim has agreed to be the designated magistrate judge in these proceedings; therefor It is hereby ordered that Judge Kennelly shall preside over pretrial proceedings, including case management and discovery supervision, in the cases listed below; and It is further order that Magistrate Judge Kim shall be the designated magistrate judge; and It is further ordered that these cases shall remain pending on the calendars of the judges to whom they are currently assigned, and that an order be entered in each case by Judge Kennelly at such time as coordinated Pretrial Proceedings) under which all future filings related to these coordinated pretrial proceedings shall be filed; and It is further ordered that the Clerk of Court shall link the individual cases listed below to 20 CV 623, In Re: Uloric Products Liability Coordinated Pretrial Proceedings. Signed by Executive Committee on 1/28/20. (smm, ) |
Filing 21 MINUTE entry before the Honorable Matthew F. Kennelly: Rule 16(b) status hearing held on 1/28/2020 with attorneys for all parties in all coordinated cases. The Court will establish a single case number for all future common filings. The Court approves the parties' status report and proposed schedule. A scheduling order will be entered once the single coordinated case number is established. Mailed notice. (mma, ) |
Filing 20 MINUTE entry before the Honorable John Robert Blakey: In light of the executive committee order #4 , which designates Judge Kennelly to preside over coordinated pretrial proceedings, the initial status conference previously scheduled in this Court for 1/23/20 is hereby stricken. Mailed notice (gel, ) |
Filing 19 NOTIFICATION of Affiliates pursuant to Local Rule 3.2 by Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals U.S.A. Inc. (Glinka Przybysz, Andrea) |
Filing 18 ANSWER to Complaint with Jury Demand and Separate or Affirmative Defenses by Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals U.S.A. Inc.(Glinka Przybysz, Andrea) |
Filing 17 Letter to Judge Blakey by Sidney J. Laurent, Jr (Hauer, Stacy) |
Filing 16 ORDER Regarding the Protocol for Production of Electronically Stored Information and Hardcopy Documents: Signed by the Honorable Matthew F. Kennelly on 1/9/2020. Mailed notice. (mma, ) |
Filing 15 STIPULATED PROTECTIVE ORDER OF CONFIDENTIALITY: Signed by the Honorable Matthew F. Kennelly on 1/9/2020. Mailed notice. (mma, ) |
Filing 14 MINUTE entry before the Honorable Matthew F. Kennelly: Joint case management conference held in this and other cases referred to Judge Kennelly for pretrial case management purposes under Internal Operating Procedure 13(e). Any obligation to comply with the Mandatory Initial Discovery Pilot Project's requirements is hereby vacated. The parties are directed to confer regarding a single, common case management schedule for all cases that are subject to the IOP 13(e) referral, a form of plaintiff's fact sheet, and other pertinent case management matters. A joint status report with the parties' joint or separate proposals, including as exhibits any proposed plaintiff's fact sheets and proposed orders, is to be filed under Case No. 19 C 4347 only by 1/24/2020. The proposed agreed confidentiality and ESI orders are to be modified to include the captions for all of the cases subject to the IOP 13(e) referral and are to be submitted in Word format to Judge Kennelly's proposed order e-mail address. A further joint case management conference before Judge Kennelly is set for 1/28/2020 at 8:45 AM. (mk) |
Filing 13 MINUTE entry before the Honorable John Robert Blakey: Defendant's unopposed motion for extension of time #6 is granted. Any answer or other responsive pleading shall be filed on or before 1/13/2020. Motion hearing set for 1/7/2020 is stricken. This case has been assigned to the calendar of the Honorable John Robert Blakey. Pursuant to General Order 17-0005, this case falls within the Mandatory Initial Discovery Pilot (MIDP) Project, and the "Standing Order in MIDP Cases" now governs the conduct of the litigants in this matter. Under the MIDP, this Court shall enforce the MIDP Standing Order via the Court's inherent authority (including the contempt of court power) and the Federal Rules of Civil Procedure. Consequently, both the parties and their attorneys are hereby ordered to review and fully comply with the MIDP Standing Order, which is available on the Court's homepage: http://www.ilnd.uscourts.gov/_assets/_documents/MIDP%20Standing%20Order.pdf. The parties are further advised that in light of the MIDP's intended goal of reducing the traditional cost and delay of federal civil litigation, this Court will not grant routine motions for extensions of time to meet the deadlines imposed by the MIDP Standing Order (even agreed motions made jointly by the parties). During the course of the litigation, the attorneys must also appear at all hearing dates set by the Court or noticed by the parties. If an attorney has a conflict with a set court date, the attorney must notify Judge Blakey's Courtroom Deputy, Gloria Lewis, at (312)818-6699. If appropriate, the Court will then reset the matter. Advising opposing counsel of a scheduling conflict is not a substitute for communicating directly with the Court. The litigants are further ordered to review and fully comply with all of this Courts own standing orders, which are available on Judge Blakey's information page on the Court's official website: http://www.ilnd.uscourts.gov/. An initial status conference is hereby set for 1/23/2020 at 9:45 a.m. in Courtroom 1203. At the status conference, the Court will discuss the MIDP and ask the parties questions to verify that they have reviewed and complied with the MIDP Standing Order. Without exception, the parties must also file a status report no later than 1/13/2020, using the model template set forth in this Court's standing order regarding Initial (or Reassignment) Status Conferences. Failure by any party to file the status report by the requisite deadline (either jointly or, if necessary, individually with an explanation as to why a joint report could not be filed) may result in a summary dismissal of the case for failure to prosecute, or an entry of default against any served defendant(s) failing to comply with this order. Mailed notice (gel, ) |
Filing 12 NOTICE of Motion by Andrea Marie Glinka Przybysz for presentment of extension of time #6 before Honorable Matthew F. Kennelly on 1/7/2020 at 09:30 AM. (Glinka Przybysz, Andrea) |
Filing 11 ATTORNEY Appearance for Plaintiff Sidney J. Laurent, Jr by Stacy Kathryn Hauer (Hauer, Stacy) |
Filing 10 ATTORNEY Appearance for Plaintiff Sidney J. Laurent, Jr by Timothy J. Becker (Becker, Timothy) |
Filing 9 ATTORNEY Appearance for Defendants Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals U.S.A. Inc. by James R M Hemmings (Hemmings, James) |
Filing 8 ATTORNEY Appearance for Defendants Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals U.S.A. Inc. by Sherry Ann Knutson (Knutson, Sherry) |
Filing 7 NOTICE of Motion by Andrea Marie Glinka Przybysz for presentment of extension of time #6 before Honorable John Robert Blakey on 1/7/2019 at 09:45 AM. (Glinka Przybysz, Andrea) |
Filing 6 MOTION by Defendants Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals U.S.A. Inc. for extension of time to answer or otherwise respond (Glinka Przybysz, Andrea) |
Filing 5 ATTORNEY Appearance for Defendants Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals U.S.A. Inc. by Andrea Marie Glinka Przybysz (Glinka Przybysz, Andrea) |
Filing 4 EXECUTIVE COMMITTEE ORDER: It appearing that, for reasons of judicial efficiency, coordinated pretrial proceedings in the cases listed below should be presided over by a single district judge as provided for by IOP13(e) and that a single magistrate judge should be designated for these cases; and It further appearing that the Hon. Matthew F. Kennelly, has agreed to preside over these proceedings; and It further appearing that Magistrate Judge Young B. Kim has agreed to be the designated magistrate judge in these proceedings; therefore It is hereby ordered that Judge Kennelly shall preside over pretrial proceedings, including case management and discovery supervision, in the cases listed below; and It is further ordered that Magistrate Judge Kim shall be the designated magistrate judge; and It is further ordered that these cases shall remain pending on the calendars of the judges to whom they are currently assigned, and that an order be entered in each case by Judge Kennelly at such time as coordinated pretrial proceedings have concluded. Signed by the Executive Committee on 12/30/2019. (sxb, ) |
Filing 3 NOTICE TO THE PARTIES - The Court is participating in the Mandatory Initial Discovery Pilot (MIDP). The key features and deadlines are set forth in this Notice which includes a link to the (MIDP) Standing Order and a Checklist for use by the parties. In cases subject to the pilot, all parties must respond to the mandatory initial discovery requests set forth in the Standing Order before initiating any further discovery in this case. Please note: The discovery obligations in the Standing Order supersede the disclosures required by Rule 26(a)(1). Any party seeking affirmative relief must serve a copy of the following documents (Notice of Mandatory Initial Discovery and the Standing Order) on each new party when the Complaint, Counterclaim, Crossclaim, or Third-Party Complaint is served. (las, ) |
Filing 2 CIVIL Cover Sheet (Hauer, Stacy) |
Filing 1 COMPLAINT filed by Sidney J. Laurent, Jr; Jury Demand. Filing fee $ 400, receipt number 0752-16524979.(Hauer, Stacy) |
SUMMONS Issued as to Defendants TAKEDA PHARMACEUTICALS AMERICA, INC., TAKEDA PHARMACEUTICALS USA, INC (pj, ) |
CASE ASSIGNED to the Honorable John Robert Blakey. Designated as Magistrate Judge the Honorable Jeffrey Cole. Case assignment: Random assignment. (pj, ) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Illinois Northern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.